As Avalo Therapeutics works to develop therapies that have the potential to address unmet medical needs, we engage with advocacy communities that reflect our areas of research. We collaborate with and support advocacy efforts that increase awareness, information, and resources for people living with serious and rare diseases.
We are committed to improving the lives of patients and families as well as supporting the healthcare professionals responsible for providing their care.
To ensure that our engagement and interactions with advocacy organizations respect the independence of all partners and are built on integrity and trust, Avalo Therapeutics aligns with the Bio Industry Organization’s guiding principles. These principles represent the highest industry standards for interactions with patient groups.
Congenital Disorders of Glycosylation (CDG)
Inflammatory Bowel Disease (IBD)
These links are provided as a convenience and are for informational purposes only. The views, opinions, and conclusions expressed in the links above do not necessarily reflect the views, opinions, and conclusions of Avalo Therapeutics, Inc. Avalo Therapeutics bears no responsibility for the accuracy, legality, or content of any external links.